| 196 | Dorsomorphin | embryo development | increase | growth involved in heart morphogenesis | GO:0003241 | Mus musculus | Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. | 18682835 |
| 197 | Dronabinol | embryo development | decrease | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | GO:0060715 | Homo sapiens | Dronabinol results in decreased syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 26070387 |
| 198 | Dronedarone | embryo development | decrease | embryonic morphogenesis | GO:0048598 | Mus musculus | Dronedarone results in decreased embryonic morphogenesis | 26385866 |
| 199 | dTMP | embryo development | related | embryo development | GO:0009790 | Mus musculus | Significantly changed metabolites in the two-cell-like cell (2CLC) compared with ES cells (ESCs) samples (Metabolomics data: liquid chromatography | 34428399 |
| 200 | dTTP | embryo development | related | embryo development | GO:0009790 | Mus musculus | Metabolite dynamics during mouse embryo development (Zygote, 2-cell, 4-cell, 8-cell, Morula, Blastocyst) (Metabolomics data: ultra-high-performance liquid chromatography coupled with hybrid quadrupole time-of-flight mass spectrometry (UHPLC | 36167681 |
| 201 | Dynorphin B? | embryo development | increase | growth involved in heart morphogenesis | GO:0003241 | Mus musculus | Dynorphin B induces cardiomyogenesis in P19 cells. | 15023550? |
| 202 | Elvitegravir | embryo development | decrease | embryonic morphogenesis | GO:0048598 | Mus musculus | elvitegravir results in decreased embryonic morphogenesis | 34515794 |
| 203 | Enniatin B1 (ENN B1) | embryo development | affect | embryo development | GO:0009790 | Mus musculus | Enniatin B1 (ENN B1) exerts cytotoxic effects on mouse blastocyst-stage embryos and induces intracellular oxidative stress and immunotoxicity in mouse fetuses. | 30259633 |
| 204 | Enniatin B1 (ENN B1) | embryo development | affect | embryo development | GO:0009790 | Mus musculus | Enniatin B induces dosage-related apoptosis or necrosis in mouse blastocysts leading to deleterious effects on embryo development. | 33106064 |
| 205 | Enniatins | embryo development | decrease | embryonic limb morphogenesis | GO:0030326 | Mus musculus | Entinostat results in decreased embryonic limb morphogenesis | 26251326 |
| 206 | Enniatins | embryo development | decrease | blastocyst growth | GO:0001832 | Mus musculus | Enniatins results in decreased blastocyst growth. | 30259633 |
| 207 | Enniatins | embryo development | decrease | inner cell mass cell proliferation | GO:0001833 | Mus musculus | Enniatins results in decreased inner cell mass cell proliferation. | 30259633 |
| 208 | Epinephrine | embryo development | decrease | embryo development | GO:0009790 | Mus musculus | [Epinephrine affects embryo implantation] which results in decreased embryo development | 31520687 |
| 209 | Epoxiconazole | embryo development | decrease | embryo development | GO:0009790 | Mus musculus | Epoxiconazole has been shown to be weakly embryotoxic in the mouse embryonic stem cell test (mEST) | 23861077 |
| 210 | Epoxiconazole | embryo development | decrease | embryo development | GO:0009790 | Homo sapiens | Epoxiconazole showed cytotoxicity from 50 ?M and upward in human induced pluripotent stem cell (hiPSC)-derived embryoid bodies (EB) | 32700165 |
